Safety and efficacy of COVID-19 Vaccine AstraZeneca: a vaccine approved for SARS-CoV-2 in Europe

Date: Tuesday March 2, 2021 Time: 7:00 PM - 8:15 PM CET

Add to your calendar

Sign up

Country

First Name

Last Name

Specialty

Institution/Hospital/Clinic Name

Would you like to pre-submit a question?

Place of Practice

Medical Identification Number

Medical Council Number

Your College

Your Role

IC Number

MMC Number

MCR Number

Speakers

Professor Tobias Welte

Professor of Pulmonary Medicine and Head of the Department of Pulmonary and Infectious Diseases at Hannover University School of Medicine, Germany

Professor Kirsty Le Doare

Professor of Vaccinology and Immunology at St George's, University of London, United Kingdom

Hugo Gomes da Silva

Global Head of Vaccines, AstraZeneca

By continuing to use this website, you consent to the terms of Webstream Communication's Privacy Policy

Disclaimer: This webinar is intended for HealthCare Professionals for medical educational purposes only. The webinar has been initiated, organized and funded by AstraZeneca

Job Code: Veeva Z4-30613
Date of Prep: 21 Feb 2021

Agenda

Thank You

The webcast will start on the Tuesday, March 2, 2021


Time

7:00 PM - 8:15 PM CET


Add a reminder

Click here to view the webcast
We use cookies to improve your browsing experience. You consent to our cookies policy if you continue to use this website.